Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: A randomised controlled trial

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Gajendragadkar, Parag R ^a   Hubsch, Annette ^a   Mäki Petäjä, Kaisa M ^a,b   Serg, Martin ^a,b   Wilkinson, Ian B ^a,c   Cheriyan, Joseph ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF TARTU   (Estonia)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ATERONON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; CAROTENOID;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART RATE; HUMAN; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULAR ENDOTHELIAL FUNCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; VITAMIN SUPPLEMENTATION; ANALYSIS; BLOOD; BLOOD FLOW; CARDIOVASCULAR DISEASES; DIET SUPPLEMENTATION; DRUG EFFECTS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; VERY ELDERLY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTENOIDS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; VASCULAR STIFFNESS;

EID: 84902583657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099070     Document Type: Article

References (51)

1. Müller-Nordhorn J, Binting S, Roll S, Willich SN (2008) An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 29: 1316-1326. doi:10.1093/eurheartj/ehm604. (Pubitemid 351768126)
2. Serra-Majem L, Roman B, Estruch R (2006) Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 64: S27-47.
3. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, et al. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99: 779-785. (Pubitemid 29083018)
4. Dehghan M, Mente A, Teo KK, Gao P, Sleight P, et al. (2012) Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary PreventionClinical Perspective A Prospective Cohort Study of 31 546 High-Risk Individuals From 40 Countries. Circulation 126: 2705-2712. doi:10.1161/CIRCULATIONAHA.112.103234.
5. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, et al. (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368: 1279-1290. doi:10.1056/NEJMoa1200303.
6. Di Mascio P, Kaiser S, Sies H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532-538. (Pubitemid 19261144)
7. Hung C-F, Huang T-F, Chen B-H, Shieh J-M, Wu P-H, et al. (2008) Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. Eur J Pharmacol 586: 275-282. doi:10.1016/j.ejphar.2008.03.001.
8. Agarwal S, Rao AV (1998) Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33: 981-984. (Pubitemid 28516475)
9. Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE, et al. (1997) Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol 146: 618-626. (Pubitemid 27454549)
10. Rissanen TH, Voutilainen S, Nyyssönen K, Lakka TA, Sivenius J, et al. (2001) Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. British Journal of Nutrition 85: 749-754. doi:10.1079/BJN2001357. (Pubitemid 32586506)
11. Rissanen TH, Voutilainen S, Nyyssönen K, Salonen R, Kaplan GA, et al. (2003) Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 77: 133-138. (Pubitemid 36015382)
12. Kim OY, Yoe HY, Kim HJ, Park JY, Kim JY, et al. (2010) Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis 208: 581-586. doi:10.1016/j.atherosclerosis.2009.08. 009.
13. Upritchard JE, Sutherland WH, Mann JI (2000) Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23: 733-738. (Pubitemid 30414184)
14. Ried K, Fakler P (2011) Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas 68: 299-310. doi:10.1016/j.maturitas.2010.11.018.
15. Stangl V, Kuhn C, Hentschel S, Jochmann N, Jacob C, et al. (2011) Lack of effects of tomato products on endothelial function in human subjects: results of a randomised, placebo-controlled cross-over study. Br J Nutr 105: 263-267. doi:10.1017/S0007114510003284.
16. Denniss SG, Haffner TD, Kroetsch JT, Davidson SR, Rush JWE, et al. (2008) Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals. Vasc Health Risk Manag 4: 213-222. (Pubitemid 351460862)
17. Kim JY, Paik JK, Kim OY, Park HW, Lee JH, et al. (2011) Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 215: 189-195. doi:10.1016/j.atherosclerosis. 2010.11.036.
18. Thies F, Masson LF, Rudd A, Vaughan N, Tsang C, et al. (2012) Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial. Am J Clin Nutr 95: 1013-1022. doi:10.3945/ajcn.111.026286.
19. Xaplanteris P, Vlachopoulos C, Pietri P, Terentes-Printzios D, Kardara D, et al. (2012) Tomato paste supplementation improves endothelial dynamics and reduces plasma total oxidative status in healthy subjects. Nutr Res 32: 390-394. doi:10.1016/j.nutres.2012.03.011.
20. Napoli C, Ignarro LJ (2009) Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32: 1103-1108. doi:10.1007/s12272-009-1801-1.
21. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376: 1670-1681. doi:10.1016/S0140-6736(10)61350-5.
22. Mora S, Wenger NK, DeMicco DA, Breazna A, Boekholdt SM, et al. (2012) Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin TherapyClinical Perspective The Treating to New Targets (TNT) Study. Circulation 125: 1979-1987. doi:10.1161/CIRCULATIONAHA.111. 088591.
23. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000. (Pubitemid 19257913)
24. Forte P, Copland M, Smith LM, Milne E, Sutherland J, et al. (1997) Basal nitric oxide synthesis in essential hypertension. Lancet 349: 837-842. doi:10.1016/S0140-6736(96)07631-3. (Pubitemid 27129211)
25. Wilkinson IB, Webb DJ (2001) Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol 52: 631-646. (Pubitemid 34015621)
26. Lind L, Berglund L, Larsson A, Sundström J (2011) Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 123: 1545-1551. doi:10.1161/CIRCULATIONAHA.110.984047.
27. O'Brien Mee, Atkins Thomas (1996) Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1: 55-61.
28. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, et al. (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16: 2079-2084. (Pubitemid 29002391)
29. Chen C-H, Nevo E, Fetics B, Pak PH, Yin FCP, et al. (1997) Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure Validation of Generalized Transfer Function. Circulation 95: 1827-1836. doi:10.1161/01.CIR.95.7.1827. (Pubitemid 27164400)
30. Pauca AL, O'Rourke MF, Kon ND (2001) Prospective Evaluation of a Method for Estimating Ascending Aortic Pressure From the Radial Artery Pressure Waveform. Hypertension 38: 932-937. doi:10.1161/hy1001.096106. (Pubitemid 34258696)
31. O'Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95: 1126-1131. (Pubitemid 27097821)
32. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. (1999) Stat Med 18: 1905-1942.
33. Winkens B, van Breukelen GJP, Schouten HJA, Berger MPF (2007) Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models. Contemp Clin Trials 28: 713-719. doi:10.1016/j.cct.2007. 04.002. (Pubitemid 47499251)
34. Kris-Etherton P, Eckel RH, Howard BV, St Jeor S, Bazzarre TL (2001) AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 103: 1823-1825. (Pubitemid 32291424)
35. Teo K LS (2013) Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The prospective urban rural epidemiology (pure) study. JAMA 309: 1613-1621. doi:10.1001/jama.2013.3519.
36. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, et al. (1997) Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95: 2617-2622. (Pubitemid 27255489)
37. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ (2002) Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin Sci 103: 339-344. doi:10.1042/.
38. Chowienczyk PJ, Kneale BJ, Brett SE, Paganga G, Jenkins BS, et al. (1998) Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease. Clin Sci 94: 129-134. (Pubitemid 28052642)
39. Gazis A, White DJ, Page SR, Cockcroft JR (1999) Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 16: 304-311.
40. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361: 2017-2023. doi:10.1016/S0140-6736(03)13637-9. (Pubitemid 36695043)
41. Wilkinson IB, Franklin SS, Cockcroft JR (2004) Nitric Oxide and the Regulation of Large Artery Stiffness From Physiology to Pharmacology. Hypertension 44: 112-116. doi:10.1161/01.HYP.0000138068.03893.40. (Pubitemid 39014221)
42. Sharman JE, McEniery CM, Campbell R, Pusalkar P, Wilkinson IB, et al. (2008) Nitric oxide does not significantly contribute to changes in pulse pressure amplification during light aerobic exercise. Hypertension 51: 856-861. doi:10.1161/HYPERTENSIONAHA.107.102558. (Pubitemid 351654695)
43. Blum A, Monir M, Khazim K, Peleg A, Blum N (2007) Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med 30: E70-74. (Pubitemid 47535695)
44. Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, et al. (2013) Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med 11: 207. doi:10.1186/1741-7015-11-207.
45. Hollman PCH, Cassidy A, Comte B, Heinonen M, Richelle M, et al. (2011) The Biological Relevance of Direct Antioxidant Effects of Polyphenols for Cardiovascular Health in Humans Is Not Established. J Nutr 141: 989S-1009S. doi:10.3945/jn.110.131490.
46. Erdman JW Jr, Ford NA, Lindshield BL (2009) Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys 483: 229- 235. doi:10.1016/j.abb.2008.10.022.
47. Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, et al. (2008) Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol 75: 1045-1053. doi:10.1016/j.bcp.2007.11.002.
48. Waddington E, Puddey IB, Croft KD (2004) Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation. Am J Clin Nutr 79: 54-61. (Pubitemid 41132062)
49. Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, et al. (1995) Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther 274: 1067-1071.
50. O'Driscoll G, Green D, Maiorana A, Stanton K, Colreavy F, et al. (1999) Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 33: 1506-1511.
51. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, et al. (2000) Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol 36: 1461-1466.